Bloomberg Anywhere Remote Login Bloomberg Terminal Demo Request


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Bloomberg Customers

Last 562.00 GBp
Change Today -6.00 / -1.06%
Volume 391.8K
BTG On Other Exchanges
As of 7:43 AM 02/8/16 All times are local (Market data is delayed by at least 15 minutes).
text size: T | T
Back to Snapshot
Company Description

Contact Info

5 Fleet Place

London, EC4M 7RD

United Kingdom

Phone: 44 20 7575 0000

Fax: 44 20 7575 0010

BTG plc, a specialist healthcare company, acquires, develops, and commercializes pharmaceutical products worldwide. It operates through three segments: Interventional Medicine, Specialty Pharmaceuticals, and Licensing. The Interventional Medicine segment offers oncology products, including Beads and TheraSphere for the treatment of liver tumours; pulmonology products comprising RePneu Coil system for the treatment of emphysema; and vascular products, such as EkoSonic for severe blood clots, as well as Varithena for moderate to severe varicose veins. The Specialty Pharmaceuticals segment provides acute care and antidote products, such as CroFab for crotalid snakebites; DigiFab for digoxin toxicity; and Voraxaze for high-dose methotrexate toxicity. The Licensing segment offers Abiraterone acetate for advanced prostate cancer; Alemtuzumab for multiple sclerosis; and Two-Part Hip Cup for hip replacement. BTG plc is also developing uridine triacetate that is in late-stage of clinical trials for life-threatening toxic side effects of overexposure to the chemotherapeutic 5-fluorouracil. The company also manufactures and commercializes therapeutic ultrasound devices. BTG plc was founded in 1948 and is headquartered in London, the United Kingdom.


Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
BTG:LN 562.00 GBp -6.00

BTG Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Impax Laboratories Inc $33.76 USD -1.14
Merit Medical Systems Inc $15.72 USD -0.49
Pfizer Ltd/India 2,208 INR -28.85
Sirtex Medical Ltd A$35.40 AUD -0.29
Medicines Co/The $31.00 USD -1.86
View Industry Companies

Industry Analysis


Industry Average

Valuation BTG Industry Range
Price/Earnings 45.7x
Price/Sales 5.1x
Price/Book 2.6x
Price/Cash Flow 26.7x
TEV/Sales 5.1x

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact BTG PLC, please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at